|
Tuesday 10th November 2020 |
Text too small? |
NZX Regulation advises that, at the request of the company, Abano Healthcare Group Limited (NZX: ABA ) ordinary shares remain in a halt.
The trading halt has been extended to allow for completion of an addendum report by Calibre Partners, the Independent Adviser under the scheme of arrangement proposal to reflect updated financial information provided by ABA, and to allow for that report to be considered by the parties to the scheme of arrangement and released.
The trading halt will remain in place until the earlier of:
• An announcement by ABA in relation to the updated information; or
• Market open on Thursday, 12 November 2020.
See the links below for more details:
ABA – Trading Halt of Securities
Source: Abano Healthcare Group Limited
No comments yet
CDI APPOINTS JULIAN SMITH AS INDEPENDENT DIRECTOR
EROAD director Cameron Kinloch to step down in March 2026
RUA - Pro Rata Rights Offer
December 8th Morning Report
GEN - Dividend Reinvestment Plan Strike Price
Fletcher Building Update on Funding Facilities
December 5th Morning Report
Pacific Edge Names Simon Flood Chairman Designate
Fonterra provides FY26 Q1 business update
Devon Funds Morning Note - 4 December 2025